Pharma CI USA Conference 2026

Every portfolio decision rests on a hypothesis about how the market will behave — and most go untested until the numbers land eighteen months later.
This session pairs the two halves of the answer. GOLF, GRG Health's KOL intelligence platform generates the hypothesis from independently moderated expert sessions with no sponsor in the room. With a verified 500K+ HCP network across 56+ countries, GOLF transforms expert oncology discussions into precise, actionable commercial insights — from signal to strategy, in real time.
AlfaKinetic, the real-time competitive intelligence platform from Anervea, a GRG Health company. 100+ sources monitored continuously, indication-first collection so day one is never empty, every signal scored against your own assets, and every decision tracked with a named owner.
Run a specialist-generated hypothesis against live signal and it resolves into one of four outcomes: confirmed, contradicted, early, or noise. Knowing which one you are in is the portfolio decision — demonstrated through a worked oncology case where belief and behaviour sat 67 points apart.
Bring the hypothesis your team is least certain about. We will show you which quadrant it falls in — and both of us will be on the floor for the duration.